PSEUDOMONAS AERUGINOSA INFECTION
Clinical trials for PSEUDOMONAS AERUGINOSA INFECTION explained in plain language.
Never miss a new study
Get alerted when new PSEUDOMONAS AERUGINOSA INFECTION trials appear
Sign up with your email to follow new studies for PSEUDOMONAS AERUGINOSA INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New weapon tested against superbug pneumonia
Disease control Not yet recruitingThis is an early safety study testing a new drug called MP101 for adults with a specific, hard-to-treat bacterial pneumonia caused by Pseudomonas aeruginosa. The main goal is to see if MP101 is safe and how it behaves in the body when given alongside standard antibiotics. It's a …
Matched conditions: PSEUDOMONAS AERUGINOSA INFECTION
Phase: PHASE1 • Sponsor: MicrobiotiX Co., Ltd • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Personalized antibiotic dosing tested to fight deadly ICU infections
Disease control Not yet recruitingThis study aims to find the best way to dose the antibiotic ceftazidime for critically ill patients in the ICU with severe infections like sepsis. It will compare a standard dosing method against a new, personalized approach that adjusts the dose based on each patient's body. The…
Matched conditions: PSEUDOMONAS AERUGINOSA INFECTION
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC